Immunohistochemical expression of the isoform B of progesterone receptor (PRB) has shown promising results in predicting the response of atypical endometrial hyperplasia (AEH) and early endometrial cancer (EEC) to conservative treatment. We aimed to calculate the accuracy of PRB as a predictive marker of conservative treatment outcome in AEH or EEC.
Predictive accuracy of progesterone receptor B in young women with atypical endometrial hyperplasia and early endometrial cancer treated with hysteroscopic resection plus LNG-IUD insertion / Raffone, Antonio; Travaglino, Antonio; Zullo, Francesco Maria; Gencarelli, Annarita; Micheli, Mariacarolina; Miranda, Sergio; De Franciscis, Pasquale; Insabato, Luigi; Di Spiezio Sardo, Attilio; Zullo, Fulvio; Bifulco, Giuseppe. - In: JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY. - ISSN 1553-4650. - 28:6(2021), pp. 1244-1253. [10.1016/j.jmig.2020.10.009]
Predictive accuracy of progesterone receptor B in young women with atypical endometrial hyperplasia and early endometrial cancer treated with hysteroscopic resection plus LNG-IUD insertion
Raffone, Antonio;Travaglino, Antonio;Gencarelli, Annarita;Insabato, Luigi;Di Spiezio Sardo, Attilio;Zullo, Fulvio;Bifulco, Giuseppe
2021
Abstract
Immunohistochemical expression of the isoform B of progesterone receptor (PRB) has shown promising results in predicting the response of atypical endometrial hyperplasia (AEH) and early endometrial cancer (EEC) to conservative treatment. We aimed to calculate the accuracy of PRB as a predictive marker of conservative treatment outcome in AEH or EEC.| File | Dimensione | Formato | |
|---|---|---|---|
|
raffone2020.pdf
accesso aperto
Licenza:
Dominio pubblico
Dimensione
3.22 MB
Formato
Adobe PDF
|
3.22 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
